Indole derivatives as cck receptor antagonists
CA 2184114 A1 · Owner: Padia, Janak Khimchand · Inventors: Horwell, David Christopher; Pritchard, Martyn Clive; Trivedi, Bharat Kalidas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel cholecystokinin antagonist of formula (I) with good bioavailability useful as an agent in the treatment of obesity hypersecretion, of gastric acid in the gut gastrin-dependent tumors, or as an antipsychotic is disclosed. Further the compound is an antianxiety agent, and antiulcer agent. It is useful for preventing the response to the withdrawal from chronic treatment with use of nicotine diazepam, alcohol, cocaine, coffee, or opioids. The compound of the invention is also useful in treating and/or preventing panic. Also disclosed is a pharmaceutical composition and processes for preparing the compound. An important feature of the instant invention is the absolute oral …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 10, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 10, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 10, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.